In a session at the recent Drug Information Association’s DIA 2013 conference in Boston, Gregg Jewett, global category leader for research and development procurement at AstraZeneca, noted that roughly 35 percent of patient-reported outcome (PRO) or clinical outcome assessment (COA) data is captured electronically. “What year is it again?” he asks.
During times of austerity & budget cuts there is a need to innovate in order to meet current demands. Now is a "window in time" for the historically conservative pharma industry to embrace the new technologies/tools/techniques that are available. This can allow for the delivery of life saving drugs to the market on time and within budget.
The opportunity for organisations with "truly" disruptive technologies cannot be understated as the industry is forced to look at HOW to innovate and what CAN be done.
In this ebook, we take a look at some of the top disruptive innovations in clinical trials.
Innovation in the following sectors are highlighted:
- industry collaboration
- data sharing & cloud technology
- adaptive trial design
- risk based monitoring
- data analytics
- patient recruitment/engagement
Interested in learning more? Join us at Disruptive Innovation in Clinical Trials happening this coming March in London. The conference will provide innovative solutions to the challenges faced in conducting clinical trials for pharmaceutical products.